JP2000511175A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511175A5
JP2000511175A5 JP1997542377A JP54237797A JP2000511175A5 JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5 JP 1997542377 A JP1997542377 A JP 1997542377A JP 54237797 A JP54237797 A JP 54237797A JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1997542377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/006801 external-priority patent/WO1997044315A1/en
Publication of JP2000511175A publication Critical patent/JP2000511175A/ja
Publication of JP2000511175A5 publication Critical patent/JP2000511175A5/ja
Abandoned legal-status Critical Current

Links

JP09542377A 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤 Abandoned JP2000511175A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1746096P 1996-05-17 1996-05-17
US60/017,460 1996-05-17
PCT/US1997/006801 WO1997044315A1 (en) 1996-05-17 1997-04-24 Biphenylsulfonamide matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2000511175A JP2000511175A (ja) 2000-08-29
JP2000511175A5 true JP2000511175A5 (enExample) 2005-01-13

Family

ID=21782716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09542377A Abandoned JP2000511175A (ja) 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤

Country Status (22)

Country Link
EP (1) EP0901466B1 (enExample)
JP (1) JP2000511175A (enExample)
KR (1) KR20000011095A (enExample)
CN (1) CN1077885C (enExample)
AT (1) ATE207891T1 (enExample)
BG (1) BG63940B1 (enExample)
BR (1) BR9710841A (enExample)
CA (1) CA2253342A1 (enExample)
CZ (1) CZ294063B6 (enExample)
DE (1) DE69707865T2 (enExample)
DK (1) DK0901466T3 (enExample)
EA (1) EA001561B1 (enExample)
EE (1) EE03965B1 (enExample)
ES (1) ES2167733T3 (enExample)
IL (1) IL126832A0 (enExample)
NO (1) NO312510B1 (enExample)
NZ (1) NZ332711A (enExample)
PL (1) PL186416B1 (enExample)
PT (1) PT901466E (enExample)
SK (1) SK282863B6 (enExample)
WO (1) WO1997044315A1 (enExample)
ZA (1) ZA974223B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690703B2 (en) * 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US6124333A (en) * 1995-06-22 2000-09-26 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
MXPA99001974A (es) * 1996-12-09 2002-03-27 Warner Lambert Co Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular.
EP1366765A1 (en) * 1996-12-17 2003-12-03 Warner-Lambert Company Llc Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
BR9714142A (pt) * 1996-12-17 2000-02-29 Warner Lambert Co Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
ID24105A (id) 1997-07-22 2000-07-06 Shionogi & Co Komposisi untuk mengobati atau mencegah glomerulopati
BR9814422A (pt) * 1997-12-23 2000-10-10 Warner Lambert Co Combinações de inibidor de ace - inibidor de mmp
PL342009A1 (en) * 1998-02-04 2001-05-07 Novartis Ag Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
JP2002506818A (ja) * 1998-03-17 2002-03-05 ワーナー−ランバート・カンパニー スタチン−マトリックスメタロプロテイナーゼ阻害剤組み合わせ物
EP0967201A1 (en) * 1998-05-20 1999-12-29 Roche Diagnostics GmbH Pharmaceutical agents containing sulfonamids as matrix metalloproteinase inhibitors
EP1097159B1 (de) 1998-07-16 2002-11-06 Aventis Pharma Deutschland GmbH Phosphin- und phosphonsäurederivate als arzneimittel
OA11584A (en) * 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
WO2001037826A1 (en) 1999-11-26 2001-05-31 Shionogi & Co., Ltd. Npyy5 antagonists
EP1331224A4 (en) * 2000-09-29 2004-03-17 Shionogi & Co THIAZOLE AND OXAZOLE DERIVATIVES
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
MXPA01013326A (es) 2001-02-14 2002-08-26 Warner Lambert Co Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
WO2003035610A1 (en) * 2001-10-26 2003-05-01 Shionogi & Co., Ltd. Sulfonamide derivative having mmp inhibitory activity
GB0314488D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Therapeutically useful compounds
BR0318625A (pt) 2003-12-04 2006-10-31 Wyeth Corp biaril sulfonamidas e métodos para usar as mesmas
CN101001834B (zh) * 2004-03-22 2011-06-29 南方研究院 基质金属蛋白酶的非肽抑制剂
CN101279956B (zh) * 2008-04-25 2011-06-15 南昌大学 一种基质金属蛋白酶抑制剂及合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
AU690703B2 (en) * 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000506514A5 (enExample)
JP2000515269A5 (enExample)
JP2000510733A5 (enExample)
JP2000501599A5 (enExample)
JP2000507746A5 (enExample)
JP2000513721A5 (enExample)
JP2000507075A5 (enExample)
JP2000513978A5 (enExample)
JP2000508070A5 (enExample)
JP2000507499A5 (enExample)
JP2000504186A5 (enExample)
JP2000506392A5 (enExample)
JP2000505983A5 (enExample)
JP2000510827A5 (enExample)
JP2000511842A5 (enExample)
JP2000516211A5 (enExample)
JP2000504462A5 (enExample)
JP2000502714A5 (enExample)
JP2001502673A5 (enExample)
JP2000511230A5 (enExample)
JP2000511972A5 (enExample)
JP2000513805A5 (enExample)
JP2000507725A5 (enExample)
JP2000503652A5 (enExample)
JP2000504716A5 (enExample)